These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12873514)

  • 1. Design and synthesis of potent and selective macrocyclic thrombin inhibitors.
    Nantermet PG; Barrow JC; Newton CL; Pellicore JM; Young M; Lewis SD; Lucas BJ; Krueger JA; McMasters DR; Yan Y; Kuo LC; Vacca JP; Selnick HG
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2781-4. PubMed ID: 12873514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2.
    Cody WL; Augelli-Szafran CE; Berryman KA; Cai C; Doherty AM; Edmunds JJ; He JX; Narasimhan LS; Penvose-Yi J; Plummer JS; Rapundalo ST; Rubin JR; Van Huis CA; Leblond L; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2503-8. PubMed ID: 10498197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1.
    Cody WL; Cai C; Doherty AM; Edmunds JJ; He JX; Narasimhan LS; Plummer JS; Rapundalo ST; Rubin JR; Van Huis CA; St-Denis Y; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2497-502. PubMed ID: 10498196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element.
    Wiley MR; Weir LC; Briggs SL; Chirgadze NY; Clawson D; Gifford-Moore DS; Schacht AL; Smith GF; Vasudevan V; Zornes LL; Klimkowski VJ
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2767-72. PubMed ID: 10509932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors.
    Isaacs RC; Newton CL; Cutrona KJ; Mercer SP; Payne LS; Stauffer KJ; Williams PD; Cook JJ; Krueger JA; Lewis SD; Lucas BJ; Lyle EA; Lynch JJ; McMasters DR; Naylor-Olsen AM; Michener MT; Wallace AA
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1536-40. PubMed ID: 21295467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.
    Mederski WW; Dorsch D; Anzali S; Gleitz J; Cezanne B; Tsaklakidis C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3763-9. PubMed ID: 15203158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of potent and highly selective thrombin inhibitors.
    Hilpert K; Ackermann J; Banner DW; Gast A; Gubernator K; Hadváry P; Labler L; Müller K; Schmid G; Tschopp TB
    J Med Chem; 1994 Nov; 37(23):3889-901. PubMed ID: 7966150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics.
    Kranjc A; Masic LP; Reven S; Mikic K; Prezelj A; Stegnar M; Kikelj D
    Eur J Med Chem; 2005 Aug; 40(8):782-91. PubMed ID: 15890436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Hauptmann J; Vieweg H; Wikström P
    J Med Chem; 1997 Sep; 40(19):3091-9. PubMed ID: 9301673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
    Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
    Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
    Wang S; Dai P; Xu Y; Chen Q; Zhu Q; Gong G
    Arch Pharm (Weinheim); 2015 Aug; 348(8):595-605. PubMed ID: 26120827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
    Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
    Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.